UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ( ) Filed by a Party other than the Registrant (X) Check the appropriate box: ( ) Preliminary Proxy Statement ( ) Confidential for Use of the Commission Only (as ( ) Definitive Proxy Statement permitted by Rule 14a-6(e)(2)) (x) Definitive Additional Materials ( ) Soliciting Material Pursuant to (Section)240.14a-11(c) or (Section)240.14a-12 ______________________Novametrix Medical Systems, Inc._________________________ (Name of Registrant as Specified In Its Charter) ___________Paul A. Cote, on behalf of Novametrix 13D Shareholders Group______ (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): ( ) $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), 14a-6(i)(2) or item 22(a)(2) of Schedule 14A. ( ) $500 per each party to the contoversy pursuant to Exchange Act Rule 14a-6(i)(3). ( ) Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. 1) Title of each class of securities to which transaction applies: _________________________________________________________________ ____________ 2) Aggregate number of securities to which transaction applies: _________________________________________________________________ ____________ 3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): _________________________________________________________________ ____________ 4) Proposed maximum aggregate value of transaction: _________________________________________________________________ ____________ 5) Total fee paid: _________________________________________________________________ ____________ DEFINITIVE PROXY STATEMENT